These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis. White L; Mirrani G; Grover M; Rollason J; Malin A; Suntharalingam J Respir Med; 2012 Mar; 106(3):356-60. PubMed ID: 22204744 [TBL] [Abstract][Full Text] [Related]
3. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
4. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection. VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017 [TBL] [Abstract][Full Text] [Related]
5. Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis. Cartlidge MK; Hill AT Expert Opin Investig Drugs; 2017 Sep; 26(9):1091-1097. PubMed ID: 28778139 [TBL] [Abstract][Full Text] [Related]
6. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Haworth CS; Foweraker JE; Wilkinson P; Kenyon RF; Bilton D Am J Respir Crit Care Med; 2014 Apr; 189(8):975-82. PubMed ID: 24625200 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for antimicrobial stewardship in bronchiectasis? Gassiep I; Chaudhuri A Chron Respir Dis; 2015 Aug; 12(3):274-5. PubMed ID: 26015462 [No Abstract] [Full Text] [Related]
8. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis. Orriols R; Hernando R; Ferrer A; Terradas S; Montoro B Respiration; 2015; 90(4):299-305. PubMed ID: 26340658 [TBL] [Abstract][Full Text] [Related]
9. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096 [TBL] [Abstract][Full Text] [Related]
10. [Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis]. Máiz Carro L Arch Bronconeumol; 2005 May; 41(5):295. PubMed ID: 15919012 [No Abstract] [Full Text] [Related]
11. Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination. McShane PJ; Weers JG; Tarara TE; Haynes A; Durbha P; Miller DP; Mundry T; Operschall E; Elborn JS Pulm Pharmacol Ther; 2018 Jun; 50():72-79. PubMed ID: 29621625 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis. Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629 [TBL] [Abstract][Full Text] [Related]
13. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427 [TBL] [Abstract][Full Text] [Related]
14. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S; Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study. Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118 [TBL] [Abstract][Full Text] [Related]
16. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. De Soyza A; Aksamit T; Bandel TJ; Criollo M; Elborn JS; Operschall E; Polverino E; Roth K; Winthrop KL; Wilson R Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29371383 [TBL] [Abstract][Full Text] [Related]
17. The clinical impact of Pieters A; Bakker M; Hoek RAS; Altenburg J; van Westreenen M; Aerts JGJV; van der Eerden MM Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635292 [No Abstract] [Full Text] [Related]
18. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR; Pressler T; Høiby N J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [TBL] [Abstract][Full Text] [Related]
19. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection]. Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860 [TBL] [Abstract][Full Text] [Related]